Dallas Flies

6PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2025
NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression.

Thejaswini Giridharan, Sora Suzuki, Anm Nazmul H Khan

|Apr 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity.

Tianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng

|Mar 01, 2024
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies.

Kushal Prajapati, Chuan Yan, Qiqi Yang

|Mar 24, 2023
Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer.

Thazin N Aung, Niki Gavrielatou, Ioannis A Vathiotis

|Jun 14, 2021
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction.

M Ines Pascoal Ramos, Linjie Tian, Emma J de Ruiter

|Dec 13, 2019
PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus.

Xue Han, Matthew D Vesely, Wendy Yang

Pageof 1